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Pityriasis lichenoides (PL) is an uncommon, acquired spectrum of cutaneous dermatoses that pose various challenges to patients as well as treating clinicians. It is a 
difficult disorder often poses a challenge to diagnose, categorize, 
and treat. In spite of these inherent obstacles, PL merits 
awareness because it has been considered as a variant of para-
psoriasis and also possesses potential to progress to cutaneous 
lymphoma [1] or an ulceronecrotic presentation, both of which 
are associated with a significant risk of mortality. The spectrum 
of PL presentations is delineated along a continuity of multiple 
variants [2], which includes pityriasis lichenoides chronica 
(PLC), pityriasis lichenoides et varioliformis acute (PLEVA), 
and febrile ulceronecrotic Mucha-Habermann disease (FUMHD), 
also known as pityriasis lichenoides with ulceronecrosis and 
hyperthermia (PLUH). The disease is very rare, worldwide, its 
incidence and prevalence are not defined. As per the literature, 
around 70 cases of FUMHD were reported (till 2016) and few 
anecdotal case reports are also present from India [3]. We report a 
case of 17-year-old male patient presenting with this rare disease 
with ulceronecrosis and responded beautifully to a course of oral 
steroid over a period of 6 weeks.
CASE REPORT
A 17-year-old male student presented to our department with chief 
complains of fever and multiple painful ulcerative lesions over 
the body. The illness started as high-grade fever without chills, 
malaise, and body ache for 5–7 days and development of skin 
lesions as reddish raised papules on the 3rd day of fever. The lesions 
first started on trunk, then gradually involved limbs and head and 
neck area. Over a period of next 2 days, these lesions increased in 
number and size, with central necrosis in few of them which further 
progressed to form ulcer and covered with thick adherent crust.
There was no history of intake of any drug, vaccination, 
upper respiratory tract infection, systemic disease before the 
onset of illness, or any sexual contact. There were no associated 
symptoms of any other system involvement such as joint pain, 
dysuria, respiratory, abdominal, or neuropsychiatric problems, 
and there was no history of similar illness in the past inpatient or 
any other family member.
On general physical examination, the patient was average built 
and well nourished. Fever was (101°F) with tachycardia (pulse 90 
beats/min) at the time of examination. Systemic examination of 
other systems and rest of the vitals were within normal limits. The 
peripheral nerves were palpable and not enlarged. On detailed 
cutaneous examination, around 40–50% of body surface area 
was involved with almost bilateral and symmetrical distribution 
of polymorphic generalized cutaneous lesions. The lesions were 
seen as discrete to coalescent, erythematous, edematous papules, 
plaques, and punched out ulceration with adherent hemorrhagic 
crusting (Figs. 1 and 2). These ulcers were multiple in number, 
round to polygonal in shapes, with size varying from 1 to 10 
cm. They had well-defined punched out margins, with necrotic 
tissue crusting on the floor, and base was free from the underlying 
tissue. The lesions were mild-to-moderate tender and indurated. 
The scalp, hair, and nail were normal.
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Based on the clinical presentation of the patient, the 
differential diagnosis of necrotizing skin infections - erythema 
nodosum leprosum necroticans, malignant syphilis, and 
ecthyma gangrenosum and cutaneous vasculitis - Wegener’s 
granulomatosis, pyoderma gangrenosum, and ulceronecrotic 
variety of PLEVA were kept.
On laboratory investigation, the complete blood count showed 
leukocytosis (total leukocyte count of 14,050 cells/L) and 
erythrocyte sedimentation rate of 32 mm. Other parameters such 
as C-reactive protein, blood sugar, urine examination (routine and 
microscopic), liver and kidney function tests, electrocardiogram, 
X-ray chest, and ultrasonography of abdomen were found to be 
normal. Venereal disease research laboratory test, Treponema 
pallidum hemagglutination test, viral markers (hepatitis B and C) 
human immunodeficiency virus test, antinuclear antibody test, 
and antinuclear cytoplasmic antibody test (ANCA-against both 
proteinase 3 and myeloperoxidase) were non-reactive/negative.
Gram stain from the skin lesions showed predominate 
neutrophils, but culture from ulcer base, blood, urine, and throat 
swab failed to grow any organism. The slit smear examination was 
negative for acid-fast bacilli. Skin biopsy from the ulcer showed 
mild edema and spongiosis of the epidermis (Fig. 3a and b). 
Dermal changes included the presence of moderate edema, 
moderately dense inflammatory infiltrate predominantly 
composed of lymphocytes, few eosinophils, and extravasated red 
blood cells. Direct immunofluorescence study was not performed 
because of unavailability.
The final diagnosis of an ulceronerotic variant of PLEVA 
was made after correlating the clinicopathological scenario. 
The patient was treated promptly with oral antibiotics, systemic 
corticosteroids 1.5 mg/kg body weight, and supportive treatment. 
The patient responded well to oral corticosteroids over a period of 
2 weeks, which allowed us further to taper the dose of steroid and 
eventual withdrawal of the same in 6 weeks duration. The papules 
and plaques healed with post-inflammatory hyperpigmentation, 
whereas ulceronecrotic lesions healed with varioliform scarring. 
The patient did not suffer from any recurrent episodes of similar 
illness in 1-year follow-up period.
DISCUSSION
PLUH represents a fulminant and potentially lethal variant of 
PLEVA. In 1916, Mucha, and in 1925, Habermann [4] reported 
an acute form of PL characterized by the abrupt onset of 
papulovesicular eruptions and described it as PLEVA or Mucha-
Habermann disease. In 1966, Degos [5] first described a rare 
variant of PLEVA, also known as FUMHD.
PLEVA and PLUH occur most commonly in children, adolescents, 
and young adults. Majority cases of FUMHD occur in the second or 
third decade of life with a male predominance [6]. The cutaneous 
lesions of PLEVA usually develop in crops, may be asymptomatic 
or mild pruritic in nature. They are polymorphic and may heal with 
varioliform scarring. These patients can also have accompanying 
constitutionals symptoms without major systemic signs. FUMHD, on 
the other hand, often starts as classic PLEVA but goes on to develop 
widespread ulceronecrotic lesions which may develop in new crops 
over many months, it is associated with a fulminating course and 
high fatality rate, particularly in adults and immunocompromised 
patients. Although the exact etiopathogenesis for PLUH is unknown, 
several reports have suggested the possibility of hypersensitivity to 
an infectious agent [7]. The elevation of microbe-specific antibody 
titers, deposition of immune complexes in dermal vessels, familial 
outbreaks [8], and associated constitutional symptoms have been 
offered as potential evidence for infectious etiology of the disease.
Another postulated mechanism for PLEVAs pathogenesis is 
lymphocytic proliferation. Lopez-Estebaranz et al. [9], however, 
implied that FUMHD represents an inflammatory disorder 
rather than a T-cell lymphoproliferative process as they did not 
detect abnormalities in T-cell receptor gene analysis of DNA 
Figure 1: Nodulo crusted lesions over face
Figure 2: Multiple large ulcerative lesions with crust and post-
inflammatory changes over thighs (a) and buttocks (b)
a b
Figure 3: Histopathology (a and b) showing epidermis with mild 
edema, spongiosis. Dermal edema with dense inflammatory infiltrate 
predominantly composed of lymphocytes, few eosinophils, and 
extravasated red blood cells
a b
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from skin lesion and peripheral blood [9]. Immune complex-
mediated vasculitis [4] has also been implicated as one of the 
etiopathogenesis mechanisms.
The management of PLUH is controversial and a considerable 
number of therapies have been tried with varied success rate. These 
include systemic corticosteroids [10], antibiotics, acyclovir, dapsone, 
methotrexate [10,11], cyclosporine [12], psoralen plus ultraviolet A, 
and tumor necrosis factor-alpha inhibitors (such as infliximab and 
etanercept) [13]. A combination of these agents has been tried in 
some patients. Prognosis of the condition is variable at times fatal, 
which is more common in adults as compared to the children [3].
In our patient, systemic corticosteroids in dosages 
>1 mg/kg per day, along with oral antibiotics, were used. 
The patient responded to this very well without any and on 
immunosuppressive or biologics.
CONCLUSION
PLUH or FUMHD is a severe disease, being a rare presentation 
of PLC, associated with a significant risk of mortality. Timely 
diagnosis, prompt management, and appropriate treatment 
according to an individual patient are important. In this patient, 
systemic corticosteroids in dosages >1 mg/kg per day, along with 
oral antibiotics, were used and proved lifesaving.
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